Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s template or content. This change does not modify the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T19:08:15.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag (v3.6.5) replacing the previous revision tag (v3.6.4), indicating a minor backend/UI update.
    Difference
    0.1%
    Check dated 2026-08-08T22:33:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.6.4, was added and the previous label, Revision: v3.6.3, was removed, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T12:36:58.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Update to revision label on the page from v3.6.2 to v3.6.3, indicating a new page version. This update likely includes minor behind-the-scenes changes without altering the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:57.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-26T23:50:52.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Recruitment status now indicates no further participant recruitment; new help sections were added to assist users in reading, understanding, and joining studies, along with minor label formatting changes and a revision tag.
    Difference
    0.5%
    Check dated 2026-06-12T16:46:55.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.